Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07001969

Percutaneous Trans-facet Spine Fixation

Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

Enrolling by Invitation

Interested in participating?

Request Info

Key information

About this study

Massoud-Goel' as rationale treatment for treatment spinal degeneration affected spinal segments using trans-articular screws, without physically distracting the facets, or removal of any part of the bone or ligament.

Following fixing of the segment, all the secondary phenomenon reverse, effectively increasing the canal size and reversing the effects of spinal degeneration and spinal canal stenosis.

Stabilizes the region and provides an environment for resorption of the herniated disc and ultimate arthrodesis of the spinal segments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For Lumbar Sub-axial cervical instability Clinical radicular symptoms can indicate the level of spinal instability. The presence of osteophytes. Reduction of the intervertebral disc space. Disc prolapse. Ligamentum flavum buckling. For atlantoaxial instability Cervical myelopathy clinical Alteration of atlantodental interval on dynamic flexion-extension images.

Exclusion criteria

  • Cauda equine syndrome
  • Progressive motor weakness
  • Failed damage control method
  • Spondylolisthesis, Spondyolysis.

Treatment and study plan

Massoud-Goel Technique and Theory

Procedure

Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine

Procedure

Percutaneous Trans-facet Fixation (Developmental of Dr Atul goel technique of transfacet fixation by open surgery using Magrel technique) Massoud-Goel Technique and Theory for Treatment of Degenerative Spine

Primary outcomes

  1. Pain relief

    Time frame: 3 months

    Relief of pain from neuralgia (sciatica & brachialgia) also claudication pain assessment by visual analogue scale 1-10

Secondary outcomes

  1. Functional recovery

    Time frame: 3 months

    functional improvement postoperatively. Secondary outcomes include functional recovery (Oswestry Disability Index score)

  2. Less complications

    Time frame: 1 year

    fusion rates (CT scan), and complication rates, assessing both efficacy and safety.

    Additional measures like hospital stay duration and patient satisfaction provide insights into procedural efficiency and patient-reported outcomes.

  3. Spinal stability

    Time frame: 6 months

    By CT spine we can assess facet fusion, stabilization of spine segmental instability

  4. Neurological decompression indirectly

    Time frame: 6 months

    Early by position of patients intraoperative and stabilization, late by healing of pathological state of ligament flavum hypertrophic changes, disc degeneration, spinal canal stenosis by Magnetic resonance imaging follow-up

Sponsors and collaborators

Lead sponsor

Mahmoud Massoud

Other

Collaborators

  • Cairo University
  • Military Academy for Medical Sciences

Registry information

Official study title

Massoud-Goel Technique and Theory: Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine

Acronym: Massoud-Goel

Important dates

Study start
2024
Primary completion
2025
Study completion
2027
First posted
Jun 3, 2025
Registry last updated
Jun 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.